Latest filing published 25 Aug 2026 for Tarsus Pharmaceuticals, Inc., €5.0M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mottiwala Aziz: trading record in brief
Mottiwala Aziz appears in our data through filings on Tarsus Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 19 August 2026 and the latest from 25 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 25 August 2026 with a transaction (€5.0M) in Tarsus Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mottiwala Aziz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 81,332 shares@ US$71.8522CommonSEC144:0001959173-26-006443
- 53,043 shares@ US$72.000.12% mcap68.0% of flowCommonSEC144:0001959173-26-006221
2 of 2 declarations
